Notice of Closed Meeting, 38096 [2021-15246]
Download as PDF
<![CDATA[
38096
Federal Register / Vol. 86, No. 135 / Monday, July 19, 2021 / Notices
or to animal or plant products (select
agents and toxins). This joint effort
constitutes the Federal Select Agent
Program. Due to the continuing
pandemic and concerns for the safety of
our workshop attendees and employees,
DSAT replaced in-person workshops
with webinars. The purpose of the
webinars is to provide guidance on
completing APHIS/CDC Form 2
(Request to Transfer Select Agents and
Toxins), APHIS/CDC Form 3 (Report of
a Release/Loss/Theft), and APHIS/CDC
Form 4 (Reporting the Identification of
a Select Agent or Toxin) (APHIS/CDC
Forms 2–4) for interested individuals.
Two sessions covering the same agenda
will be held to provide two
opportunities for interested individuals
to participate.
DATES: The webinars will be held
October 6, 2021 from 10 a.m. to 12:30
p.m. (EDT) and November 3, 2021 from
1:30 p.m. to 4:00 p.m. (EDT).
Registration instructions are found on
the website, https://
www.selectagents.gov.
The webinars will be
conducted from the Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, Atlanta, Georgia 30329.
FOR FURTHER INFORMATION CONTACT:
CDC: Samuel S. Edwin, Ph.D., Director,
DSAT, Center for Preparedness and
Response, CDC, 1600 Clifton Road NE,
MS H–21–7, Atlanta, Georgia 30329.
Telephone: (404) 718–2000; email:
lrsat@cdc.gov. APHIS: Jack Taniewski,
DVM, Director, DASAT, APHIS, 4700
River Road, Unit 2, Riverdale, MD
20737. Telephone: (301) 851–2070;
email: DASAT@usda.gov.
SUPPLEMENTARY INFORMATION: The two
public webinar sessions covering the
same content, scheduled for
Wednesday, October 6, 2021 and
Wednesday, November 3, 2021, are
opportunities for interested individuals
to obtain guidance on completing the
APHIS/CDC Forms 2–4 and reporting
requirements related to the select agent
and toxin regulations (7 CFR part 331,
9 CFR part 121 and 42 CFR part 73). For
individuals not able to attend the
webinars, the information will be
available under the training section at
https://www.selectagents.gov.
Representatives from the Federal
Select Agent Program will be present
during the webinars followed by
question and answer session to address
questions and concerns from the
webinar participants.
Participants who want to participate
in the webinar should complete their
registration online by September 18,
2021. The registration instructions are
lotter on DSK11XQN23PROD with NOTICES1
ADDRESSES:
VerDate Sep<11>2014
18:23 Jul 16, 2021
Jkt 253001
located on this website: https://
www.selectagents.gov.
Dated: July 14, 2021.
Sandra Cashman,
Executive Secretary, Centers for Disease
Control and Prevention.
[FR Doc. 2021–15305 Filed 7–16–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463.
Name of Committee: Safety and
Occupational Health Study Section
(SOHSS), National Institute for
Occupational Safety and Health
(NIOSH).
Dates: October 20–21, 2021.
Time: 11:00 a.m.–5:00 p.m., EDT.
Place: Teleconference.
Agenda: The meeting will convene to
address matters related to the conduct of
Study Section business and for the
study section to consider safety and
occupational health-related grant
applications.
For Further Information Contact:
Michael Goldcamp, Ph.D., Scientific
Review Officer, NIOSH, CDC, 1095
Willowdale Road, Morgantown, WV
26506; Telephone: (304) 285–5951;
Email: mgoldcamp@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–15246 Filed 7–16–21; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00110
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–21–21DC]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled National
Syringe Services Program (SSP)
Evaluation to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on February
25, 2021 to obtain comments from the
public and affected agencies. CDC
received three public comments related
to the previous notice. This notice
serves to allow an additional 30 days for
public and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
E:\FR\FM\19JYN1.SGM
19JYN1
]]>Agencies
[Federal Register Volume 86, Number 135 (Monday, July 19, 2021)]
[Notices]
[Page 38096]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-15246]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463.
Name of Committee: Safety and Occupational Health Study Section
(SOHSS), National Institute for Occupational Safety and Health (NIOSH).
Dates: October 20-21, 2021.
Time: 11:00 a.m.-5:00 p.m., EDT.
Place: Teleconference.
Agenda: The meeting will convene to address matters related to the
conduct of Study Section business and for the study section to consider
safety and occupational health-related grant applications.
For Further Information Contact: Michael Goldcamp, Ph.D.,
Scientific Review Officer, NIOSH, CDC, 1095 Willowdale Road,
Morgantown, WV 26506; Telephone: (304) 285-5951; Email:
[email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-15246 Filed 7-16-21; 8:45 am]
BILLING CODE 4163-18-P
